Lantheus Holdings, Inc.

NASDAQ:LNTH

91.58 (USD) • At close January 16, 2025
Bedrijfsnaam Lantheus Holdings, Inc.
Symbool LNTH
Munteenheid USD
Prijs 91.58
Beurswaarde 6,367,264,344
Dividendpercentage 0%
52-weken bereik 50.2 - 126.89
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Mary Anne Heino
Website https://www.lantheus.com

An error occurred while fetching data.

Over Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to

Vergelijkbare Aandelen

Premier, Inc. logo

Premier, Inc.

PINC

22.03 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

336.82 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

136.33 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

29.73 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

37.53 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

166.07 USD

Alkermes plc logo

Alkermes plc

ALKS

29.75 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

41.88 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)